Sign in

CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company

TENAX THERAPEUTICS, INC.

Sign in to watch
Ticker
TENX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
262593535
Phone
919-855-2100
Business address
101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
Former names
OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
  1. 4 Open-market buy 10% owner bought 1,025,867 shares at an average $1.77 ($1,814,147)
  2. 3 Insider Initial Statement of Ownership
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. 8-K Event Other events
  12. SCHEDULE 13D/A Stake Beneficial Ownership Report
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. SCHEDULE 13G Stake Statement of Beneficial Ownership
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. 4 Option exercise CEO acquired 8,719 shares (option exercise)
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. 8-K Event Other events
  20. 8-K Event Material agreement

Page 2 of 50 · 996 filings